As of 2025-04-19, the Relative Valuation of Mirati Therapeutics Inc (MRTX) is (164.01) USD. This relative valuation is based on P/E multiples. With the latest stock price at 58.70 USD, the upside of Mirati Therapeutics Inc based on Relative Valuation is -379.4%.
The range of the Relative Valuation is (154.80) - (176.32) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.0x - 19.9x | 16.4x |
| Forward P/E multiples | 13.9x - 17.0x | 15.3x |
| Fair Price | (154.80) - (176.32) | (164.01) |
| Upside | -363.7% - -400.4% | -379.4% |
| Date | P/E |